YMAB: Y-mAbs Therapeutics, Inc. Stock

by  •  • Comments Off on YMAB: Y-mAbs Therapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 509.04
Enterprise Value ($M) 433.29
Book Value ($M) 99.19
Book Value / Share 2.26
Price / Book 5.13
NCAV ($M) 84.14
NCAV / Share 1.92
Price / NCAV 6.05

Profitability (mra)
Return on Invested Capital (ROIC) -0.22
Return on Assets (ROA) -0.16
Return on Equity (ROE) -0.20

Liquidity (mrq)
Quick Ratio 5.67
Current Ratio 6.15

Balance Sheet (mrq) ($M)
Current Assets 108.27
Assets 123.31
Liabilities 24.13
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 84.82
Operating Income -25.67
Net Income -21.43
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -27.23
Cash from Investing 0.00
Cash from Financing 0.10

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
04-08 13G Paradigm Biocapital Advisors LP 5.02
02-14 13G/A WG Biotech ApS 10.70 9.18
02-13 13G/A Vanguard Group Inc 5.14 -0.62
02-13 13G/A HBM Healthcare Investments (Cayman) Ltd. 7.60 -13.53
02-06 13G/A Acorn Bioventures, L.p. 6.30 18.71
01-26 13G/A BlackRock Inc. 6.70 13.12

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-05-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-02-29 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-08-10 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-17 37,016 351,211 10.54
2024-05-16 25,629 207,629 12.34
2024-05-15 26,068 267,473 9.75
2024-05-14 45,950 427,141 10.76
2024-05-13 47,679 543,801 8.77

(click for more detail)

Similar Companies
XBIT – XBiotech Inc. XERS – Xeris Biopharma Holdings, Inc.
XLO – Xilio Therapeutics, Inc. ZVRA – Zevra Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io